Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00409201
Show Display Options
Rank Status Study
1 Unknown  Reboxetine Adjuvant Therapy for the Treatment of Schizophrenia
Condition: Schizophrenia
Intervention: Drug: reboxetine adjuvant therapy

Study has passed its completion date and status has not been verified in more than two years.